Fig. 1: Differences in post-remission 5-year risk of hospitalization between DLBCL survivors and matched comparators from the Danish general population. | Blood Cancer Journal

Fig. 1: Differences in post-remission 5-year risk of hospitalization between DLBCL survivors and matched comparators from the Danish general population.

From: Patients in complete remission after R-CHOP(-like) therapy for diffuse large B-cell lymphoma have limited excess use of health care services in Denmark

Fig. 1

The differences are reported overall and within clinical subgroups. Elevated risks of hospitalization among DLBCL survivors correspond to a positive risk difference and error bars indicate 95% confidence intervals. ECOG PS Eastern Cooperative Oncology Group performance status.

Back to article page